BXPLANT Co-CEOs Minkeun Jo and Heesun Kim hosted a strategic member meeting with the Korea Biotechnology Industry Organization (KoreaBIO), engaging in productive discussions on the future direction of Korea’s bio industry.
The meeting, which included KoreaBIO Vice Chairman Seung Kyu Lee and Executive Director Soo Jung Park, focused on the theme “What Members Expect from the Association.” Participants shared candid perspectives on how the industry association can better support its members in navigating the rapidly evolving bio healthcare landscape.
BXPLANT’s leadership emphasized the critical need for enhanced collaboration between industry stakeholders, particularly in areas such as regulatory advocacy, global market access, and fostering innovation ecosystems for emerging biotech companies. The discussion highlighted opportunities for KoreaBIO to serve as a more robust platform connecting startups with established pharmaceutical companies, research institutions, and investment networks.
Both parties expressed optimism about the synergies that can be achieved through closer cooperation. As a CDRO and scalerator specialist, BXPLANT looks forward to actively collaborating with KoreaBIO to strengthen Korea’s position in the global bio economy, accelerate the growth of member companies, and create a more supportive environment for breakthrough innovations that will benefit patients worldwide.
This ongoing dialogue underscores BXPLANT’s commitment to contributing to the collective advancement of Korea’s biotechnology industry through active industry engagement and partnership.
Attendees:
🔹Seung Kyu Lee, Vice Chairman (KoreaBIO)
🔹Soo Jung Park, Executive Director (KoreaBIO)
🔹Heesun Kim, Co-CEO (BXPLANT)
🔹Minkeun Jo, Co-CEO (BXPLANT)
